Functional Mushroom Company Hypha Labs Retains Emerging Markets Consulting LLC for Investor Relations Advisory Services

September 26, 2024 9:30 AM

Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has retained Emerging Markets Consulting, LLC (EMC) to provide investor and public relations services. EMC specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community."As we draw...

Read more

Cordovacann (CSE: CDVA / OTCQB: LVRLF) Provides Update on Star Buds Cannabis Co. Retail Operations

September 26, 2024 9:15 AM

Star Buds Cannabis Co. Stores Achieve Record Month in AugustTORONTO, ON / ACCESSWIRE / September 26, 2024 / CordovaCann Corp. (CSE:CDVA)(OTCQB:LVRLF) ("Cordova" or the "Company"), a cannabis-focused consumer products company, proudly announces an update on its Star Buds Cannabis Co. retail operations in Canada.Star Buds Cannabis Co. stores produced strong growth in the spring and summer and are expected to sustain this growth heading into the...

Read more

Reveal MRI Launches the Reveal Total Scan: A Breakthrough in Preventative Health Screening

September 26, 2024 9:00 AM

HENDERSON, NV / ACCESSWIRE / September 26, 2024 / In early 2024, Reveal MRI (www.revealmri.com) introduced an innovative full-body MRI program in Henderson, Nevada, designed to provide preventative screening from head to waist. This initiative empowers individuals to take control of their health by detecting cancer and other significant diseases early, often before symptoms appear. The standard healthcare model is largely reactionary, typically...

Read more

Saint Therese Opens New Senior Living Community - Saint Therese of Corcoran - in Growing West Metro City of Corcoran

September 26, 2024 9:00 AM

Sixty years after its founding in 1964, Saint Therese has opened a new senior living community in Corcoran, Minn., a growing city in the west metro. With Saint Therese of Corcoran, the nonprofit organization now has four communities in the Twin Cities and one in Monroe, Mich.Saint Therese of Corcoran opened on Monday, September 16, welcoming its first residents into the independent living apartments. More than 55 families will be moving in over...

Read more

Aesthetic Surgery Center Wins 1st Place in Three Categories in the 2024 Naples Community's Choice Awards

September 26, 2024 9:00 AM

Aesthetic Surgery Center excels in Naples' 2024 Community's Choice Awards, earning top honors for its expertise in facial and body surgeries, led by renowned surgeons Dr. Agarwal, Dr. Maloney, and Dr. Holmes.NAPLES, FL / ACCESSWIRE / September 26, 2024 / Aesthetic Surgery Center has received three exceptional awards from Naples Community's Choice Awards in the Beauty and Health category. This achievement highlights the Aesthetic Surgery Center...

Read more

Stemtech Sets Strategic Directions and Expands Into $303 Billion Pet Health Market, Boosted by Increased Demand For Anti-Aging Innovations

September 26, 2024 8:30 AM

NAPLES, FL / ACCESSWIRE / September 26, 2024 / STEMTECH CORPORATION, ("STEK") Stemtech Corporation, a pioneer in the health and wellness industry specializing in stem cell nutrition, is excited to announce a strategic realignment of its market focus to accelerate growth and enhance profitability. This move comes alongside a significant expansion into the burgeoning $303 billion pet health care market with the launch of StemPets™ and a reinforced...

Read more

Biotricity Announces Inclusion as a Supplier to A Prominent Medical System That Services 21 States

September 26, 2024 8:15 AM

Biotricity Inc. (OTCQB:BTCY), a leading Technology-as-a-Service (TaaS) company that is redefining the healthcare industry with cutting-edge remote monitoring and diagnostic solutions, announces its inclusion as a supplier to another major medical system that encompasses 60,000 care providers over 400 hospitals and 400 care centers. In the U.S. today, 121.5 million adults have some form of cardiovascular disease. Yet nearly half of U.S. counties...

Read more

CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024

September 26, 2024 8:00 AM

SCOTTSDALE, AZ / ACCESSWIRE / September 26, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD and wellness industry, is proud to announce an extraordinary revenue increase of 1405.46% since February 2024. This exceptional growth highlights the company's successful strategic initiatives and the increasing market demand for its premium CBD products. "This significant milestone reflects our commitment to innovation,...

Read more

Sunshine Biopharma Launches Two New Generic Prescription Drugs

September 26, 2024 8:00 AM

Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that its wholly owned Canadian subsidiary, Nora Pharma Inc., has launched two new generic prescription drugs.The first product is Varenicline, a generic version of Champix®. Varenicline is used as a smoking cessation product and is...

Read more

PharmaCord Announces Completion of Permira Investment

September 26, 2024 8:00 AM

Investment will enable PharmaCord to accelerate its technology roadmap and expand into additional commercialization service lines for its life sciences clients.JEFFERSONVILLE, IN / ACCESSWIRE / September 26, 2024 / PharmaCord LLC ("PharmaCord" or the "Company"), a leading provider of patient services and commercialization solutions to life sciences companies, today announced that funds advised by Permira, the global investment firm, have...

Read more

Notice of Extraordinary General Meeting in PMD Device Solutions AB (PUBL)

September 26, 2024 7:45 AM

STOCKHOLM, SWEDEN / ACCESSWIRE / September 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) The shareholders of PMD Device Solutions AB (publ), reg. no. 556639-6809 (the "Company"), are hereby invited to an extraordinary general meeting on 29 October 2024 at 10:00 CET at the premises of Eversheds Sutherland located at Sveavägen 20, Stockholm. Registration begins at 09:45.RIGHT TO PARTICIPATE AND NOTIFICATIONShareholders who wish to...

Read more

Natural Scientific Sparks a Revolution in the U.S. Supplement Market with 20 New All-Natural Products

September 26, 2024 7:35 AM

Natural Scientific, a Florida-based brand, is rapidly gaining attention for its innovative, plant-based supplements, setting a new standard in a market often clouded by low-quality or poorly formulated products. With the U.S. supplement market projected to surpass $70 billion by 2028, Natural Scientific is standing out from the competition by delivering what modern consumers are demanding-premium, cruelty-free, and all-natural products backed by...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Secures Exclusive Distribution for CLMBR with PrimaFit in Fast-Growing Indonesia and Already Receives Second Order in Third Quarter

September 26, 2024 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that, it has secured exclusive distribution and received two orders in the third quarter for CLMBR in the fast-growing Indonesia with PrimaFit, the leading distributor of best-in-class brands in the country.Trent Ward, Co-Founder and CEO of TRNR, said: "Indonesia is a very...

Read more

Hoggan Scientific Reinforces Commitment to Precision With Handheld Dynamometer for Muscle Strength Testing

September 26, 2024 7:00 AM

MicroFET2 is a valuable asset for clinical trials and research projects.SALT LAKE CITY, UT / ACCESSWIRE / September 26, 2024 / Hoggan Scientific, LLC, a global leader in medical device manufacturing, is proud to highlight the capabilities of its trusted handheld dynamometer, the MicroFET2, an essential tool for accurate muscle strength testing. MicroFET2 meets the rigorous demands of clinical trials and research environments, excelling in these...

Read more

NanoViricides Executes an Agreement Encompassing All Antiviral Drug Treatments With Theracour, Including “Trojan Horse” Drugs

September 26, 2024 6:30 AM

NanoViricides, Inc. (NYSE American.:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, reports today that it has now obtained a right of first refusal (ROFR) for all antiviral drug developments from the R&D firm TheraCour Pharma, Inc. ("TheraCour").NanoViricides has signed a broad Memorandum of Understanding Agreement (MoU) with TheraCour encompassing all antiviral drugs developments on September 23,...

Read more

BioNxt Provides Update on Cladribine Program for Multiple Sclerosis, Sublingual Neurodegenerative Disease Patent, and Investor Relations Activities

September 26, 2024 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to provide an update on its flagship sublingual Cladribine drug formulation program for the treatment of Multiple Sclerosis ("MS"), broad sublingual patent application for the use of anticancer drugs for the treatment of autoimmune neurodegenerative diseases, and investor relations activities.BioNxt's lead program is the development of a 100% owned...

Read more

Angle PLC Announces 100th Publication Supporting Parsortix System Use

September 26, 2024 2:01 AM

Whole Genomic Sequencing and machine learning identifies key cancer genes associated with DNA proliferation and repairANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of the 100th peer-reviewed journal article using the Parsortix® system for the isolation, harvest and...

Read more

Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies

September 26, 2024 2:00 AM

Evotec SE (Frankfurt Stock Exchange:EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy.Both Evotec and Novo Nordisk have significant expertise and a strategic focus to support stem cell-based therapies. In order to provide next-generation off-the-shelf cell therapy products for clinical development and possible commercialisation...

Read more

Angle PLC Announces Half-year Report

September 26, 2024 2:00 AM

ANGLE plc ("ANGLE" or "the Company") ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, today announces unaudited interim results for the six months ended 30 June 2024.Financial HighlightsRevenues for the half-year of £1.0 million (H1 2023: £1.2 million)- sold order book of up to £1.9 million at period...

Read more

Applied Science Releases New Advanced Technologies to Improve Care for People Living With Diabetes in Rural and Under-Served Communities

September 25, 2024 10:00 PM

Co-created With Sierra Family Health Center and Western Sierra Medical Clinic, the Applied Science AdaptivMD Solution Integrates the Verily Retinal Service and eClinicalWorks EHR -- Raising The Bar For Early Detection of Diabetic RetinopathyGRASS VALLEY, CA / ACCESSWIRE / September 25, 2024 / Applied Science, Inc. (ASI), a leading provider of workflow automation and data integration platforms for whole blood collection and chronic care...

Read more